 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| BICX Announces Start Date for So Cal Wellness Center = Progress! |
|
 Hot Stock to Watch
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
End of Day:
Price: 0.0923
Change (%): - 0.0027 (2.84)
Volume: 66,524 |
 |
BioCorRx, Inc. Announces Start Date of Start Fresh Program(r) Pilot at Wellness Center in Corona, CA
Los Angeles, April 14, 2015 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the Company’s pilot program that was created as a result of an agreement with Myriad Medical Marketing (MMM) is scheduled to launch later this month. As of April 27, 2015 Corona Physical Medicine (CPM) in Corona, CA plans to begin setting appointments with potential patients. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide.
“We are excited about the launch of the pilot program, as it is the first step towards executing on our desire to expand to numerous established wellness centers throughout the country. We believe that the relationships with these centers will be highly beneficial to those who need help with their addiction. We believe that the broad range of wellness services available to patients affords the opportunity to create highly customizable courses of treatment to not only recover from addiction, but to reclaim their overall health,” stated COO & interim CEO, Brady Granier.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Terra Tech Corp (OTCQB: TRTC) |
End of Day:
Price: 0.211
Change (%): + 0.005 (2.43)
Volume: 971,784 |
 |
IVXX Premium Quality Cannabis Extracts are now Available at Premier Sherman Oaks Medical Cannabis Dispensary
Oakland, April 13, 2015 (GLOBE NEWSWIRE) - Terra Tech Corp (TRTC), is pleased to update shareholders on the continued development of IVXX branded cannabis products. The Company is proud to announce that their brand of exceptional quality cannabis products is now available in Sherman Oaks, California at the The Apothecary Collective. Apothecary is one of Sherman Oaks premier medical cannabis facilities.
“We are thrilled that the IVXX brand is now available to patients in Sherman Oaks, and are excited that we added another patient centric retailer” explains Derek Peterson, CEO of Terra Tech. “We are pleased that our IVXX extracts meet the rigorous standards for quality, consistency and efficacy they demand for their patients. We are seeing solid demand and we are working diligently to increase both production as well as product offerings.”
Continue Reading |
Other Small Cap News
|
Company: Marley Coffee (OTCQB: JAMN)
|
Marley Coffee Showcases Innovative and Award-Winning Recyclable RealCup™
Marley Coffee, Recyclable RealCup™ Featured on MSNBC, FOX Business and Bloomberg Television
DENVER--(BUSINESS WIRE)--Marley Coffee (OTCQB:JAMN), the sustainably grown, ethically farmed and artisan-roasted premium coffee company, has recently been recognized for excellent taste and championing innovative sustainable leadership for the recyclable RealCup™, a sustainable and easy-to-recycle single-serve capsule that’s compatible with most Keurig® K-Cup® machines. With recent concerns about the K-Cup®’s negative impact on the environment, Marley Coffee has seized the opportunity to speak out about the brand and the recyclable RealCup™ in recent interviews with MSNBC’s “NewsNation with Tamron Hall,” FOX Business’s “Varney & Company,” and Bloomberg “Market Makers.”
“When I got into this business, I wanted to do something for the community-both around our coffee farm and for the worldwide community as a whole,” said Rohan Marley, Chairman of Marley Coffee. “In life you have to put yourself forward. You have to plant the seeds and watch yourself grow. Our recyclable RealCup™ is a sustainable solution that will benefit all communities and we’re proud of the recognition for our commitment to sustainability and the new packaging that will help call out this benefit to consumers.”
Continue Reading
|
Company: PharmaCyte Biotech, Inc. (OTCQB: PMCB)
|
PharmaCyte Biotech Appoints Former Pfizer and Alchemia Executive to Board of Directors
SILVER SPRING, Md., April 14, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that Thomas Liquard has joined its Board of Directors and will become Chairman of the Audit Committee. Mr. Liquard is a seasoned pharmaceutical industry executive whose past experiences include serving as Chief Executive of Alchemia Limited and as Senior Director, Portfolio Development Leader, Emerging Markets for the Established Products portfolio for Pfizer in New York.
"On behalf of our management team and Board of Directors, it is a pleasure to welcome Thomas to PharmaCyte Biotech. His specific healthcare sector expertise across product and business development, commercialization and managerial leadership will be an invaluable asset to our team as the PharmaCyte Biotech enters its next phase of growth," commented Kenneth L. Waggoner, Chief Executive Officer of PharmaCyte Biotech.
Continue Reading |
Market News
|
By Peter Schacknow: CNBC
|
Early movers: JPM, DD, NSC, BABA, WFC, JNJ & more
Check out which companies are making headlines before the bell:
JPMorgan Chase - The bank earned $1.45 per share for the first quarter, 5 cents above estimates, with revenue also above Street forecasts. CEO Jamie Dimon said the company is getting safer and stronger, as well as gaining market share.
Johnson & Johnson - The medical device maker beat estimates by 2 cents with adjusted profit of $1.56, with revenue also above estimates. J&J did say that currency hurt Q1 sales by 7.2 percent, and it lowered its full-year guidance due to the impact of the stronger dollar.
Wells Fargo - The bank reported quarterly profit of $1.04 per share, 6 cents above estimates, with revenue also above forecasts. The report did break an 18-quarter streak of higher year-over-year earnings, as the bank deals with the impact of a lower interest rate environment.
Continue Reading
|
By Jim Cramer: CNBC
|
Cramer: Go for it! Dream big for your portfolio
On a day like Monday, when the averages ended in the red, Jim Cramer thinks it is time to start to dream big with your portfolio. Many stock valuations are trapped by the index to which they belong, the ETF that claims them, or analysts' traditional methods of valuation.
Now, it is time to throw that all out the window.
Cramer thinks that some stocks are undervalued simply because investors just can't think big enough and imagine what could happen in the future. And there could be big bucks in store if investors try to think outside of the box and attribute a small portion of their portfolio to dreaming big.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
